Discontinued — last reported Q3 '23

Products & Services · Equipment And Services Received

Sequencing Services — Equipment And Services Received

Natera, Inc. Sequencing Services — Equipment And Services Received increased by 40.0% to $1.40M in Q3 2023 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ2 2023
Last reportedQ3 2023

How to read this metric

An increase suggests active expansion of testing capacity or technological upgrades, whereas a decrease may signal a slowdown in capital investment or a shift toward asset-light operational models.

Detailed definition

This metric tracks the value of equipment and specialized services acquired or received by the Sequencing Services segme...

Peer comparison

Similar to capital expenditure disclosures in other biotech firms, this metric highlights the physical and service-based resources fueling diagnostic revenue growth.

Metric ID: ntra_segment_sequencing_services_equipment_and_services_received

Historical Data

2 periods
 Q2 '23Q3 '23
Value$1.00M$1.40M
QoQ Change+40.0%
Range$1.00M$1.40M

Frequently Asked Questions

What is Natera, Inc.'s sequencing services — equipment and services received?
Natera, Inc. (NTRA) reported sequencing services — equipment and services received of $1.40M in Q3 2023.
What does sequencing services — equipment and services received mean?
The value of equipment and support services obtained for the Sequencing Services segment.